Press Release ImmunoMet Therapeutics, Inc., ("ImmunoMet", or the "Company"), a clinical stage biotechnology company committed to giving patients a novel approach to fight cancer, today provided a data ...

Adolescents receive a weight-based dose equivalent to the 50 mg adult dose Adolescents 12-17 years old who complete participation in the pharmacokinetic (PK) run-in study will be eligible to screen in ...

Phase 2 randomized study of ELI-002 fully enrolled, with formal interim analysis of disease-free survival (“DFS”) expected in H1 2025; positive results could support rapid advancement into Phase 3 ...

The federal agency has registered the case on April 19 based on a reference from the ministry of home affairs (MHA), which ...

One year after surgery, 97% of patients in the ≥ 85 group and 100% of patients in the control group could void spontaneously.

A HUGE study that has been launched to find treatments for diseases by measuring how the proteins circulating in our bodies ...

Sana is a gene and cell therapy clinical-stage biotech firm and a penny stock that has fallen by 48.5% in the year leading to January 17, 2025. What may set this company apart from a host of similar ...

Scientists in Aberystwyth are working on ways of creating new food out of bread crusts. Academics at Aberystwyth University ...

Researchers at the Center for Advanced Bioenergy and Bioproducts Innovation (CABBI) have developed a new sorghum variant that ...

CABBI scientists have developed a lab-to-field pipeline to deliver sorghum that’s high in TAG. The researchers engineered ...

Celery, a key vegetable in the Apiaceae family, is widely valued for its nutrition and medicinal uses. It is commonly ...

Researchers from China have developed a dual-reactor system that efficiently produces high-quality protein from CO2.